Latest News

Medtronic stock has delivered a decline of 26.0% over the past five years, yet its current checks point to a picture that is broadly in line with the intrinsic value estimate from a Discounted Cash Flow (DCF) model and an earnings multiple that screens as undervalued. Over a 5 year window, Medtronic has fallen 26.0%, which puts more focus on whether the current price reflects a reset in expectations rather than clear upside. Recent moves, including the SPR Therapeutics acquisition and...

With New Zealand inflation running at 1.5% for the June quarter and 4.1% year over year, many investors are rethinking how their portfolios might cope if the RBNZ lifts interest rates sooner or more sharply. Defensive consumer staples can look relatively appealing when borrowing costs rise and household budgets tighten, because they focus on everyday essentials. This article focuses on three stocks from a Defensive Consumer Staples Stocks screener that appear positively exposed to these...

Upcoming earnings put Quanta Services in focus Quanta Services (PWR) heads into its July 30 earnings release with the stock recently closing at $639.20, while consensus points to higher quarterly earnings per share and revenue compared with the same period last year. See our latest analysis for Quanta Services. Quanta Services’ share price has pulled back over the past month, with a 1‑month share price return of down 8.98%. However, the year‑to‑date share price return of 45.38% and 1‑year...

Why Levi Strauss Stock Is Back in Focus Levi Strauss (LEVI) moved back onto investor radar after reporting higher second quarter and first half earnings and revenue, while also raising full year revenue guidance and lifting its quarterly dividend by 14%. See our latest analysis for Levi Strauss. Levi Strauss shares have been gaining ground, with a 7.62% 90 day share price return and 17.96% year to date share price return, while the 3 year total shareholder return of 87.95% points to momentum...

Reshoring is moving from political slogan to hard capital spending, and aluminium is suddenly in the spotlight. With the US administration offering tariff relief on qualifying raw aluminium imports for companies that commit to domestic smelting projects, investors are asking which stocks could stand to benefit most from this policy shift. The focus is not just on metals, but on the broader network of businesses tied to defense supply chains and critical infrastructure. This article walks...

Boliden (OM:BOL) has put Q2 2026 on the table with revenue of SEK25.7b and basic EPS of SEK7.80, against a trailing twelve month picture showing SEK103.7b in revenue and basic EPS of SEK44.63 as earnings grew 57.7% over the past year. Over recent quarters, the company has seen revenue move from SEK21.1b in Q1 2025 to SEK27.8b in Q1 2026, with basic EPS ranging from SEK2.02 in Q2 2025 up to SEK15.31 in Q4 2025 and SEK13.45 in Q1 2026. This sets up the latest print against a backdrop of an...

Chemtrade Logistics Income Fund recently secured final approval for the rezoning of its North Vancouver chlor-alkali facility, allowing liquid chlorine production to continue until the earlier of its Vancouver Fraser Port Authority lease expiry or 2046 and enabling planned safety upgrades under a new restrictive covenant with the District. This agreement not only extends operational certainty for a key asset, but also formalizes community oversight and safety reporting, potentially reducing...

Maze Therapeutics (MAZE), a clinical stage biopharmaceutical company, has drawn investor attention after recent trading. The stock last closed at $29.30 and has shown mixed returns over the past week and month. See our latest analysis for Maze Therapeutics. Looking beyond the latest move to $29.30, Maze Therapeutics has seen a 14.10% 1 month share price return and a 10.57% 3 month share price return, while its year to date share price return is down 26.33% and the 1 year total shareholder...

AMC Entertainment Holdings (AMC) opened Q2 2026 with revenue of US$1.6 billion and a loss of US$11.4 million, translating to basic EPS of a US$0.02 loss, providing a clear snapshot of where the business stands coming out of the latest quarter. The company reported quarterly revenue of US$1.40 billion in Q2 2025 and US$1.60 billion in Q2 2026, while quarterly basic EPS moved from a US$0.01 loss to a US$0.02 loss, which keeps the focus on how efficiently the larger top line is translating into...

In recent weeks, Lattice Semiconductor reported a strong first quarter with revenue and EPS growth surpassing analyst expectations, while its MachXO5-NX TDQ FPGA family earned a Gold Globee® award for first-to-market innovation in post-quantum security. Analysts have since raised earnings estimates and upgraded the stock’s rating, suggesting that Lattice’s innovation in secure, low-power FPGAs is reshaping perceptions of its long-term business strength. Now we’ll examine how this earnings...

What Roche Holding’s FDA Priority Review Could Mean for Investors Roche Holding (SWX:ROP) is back in focus after the US Food and Drug Administration granted Priority Review to its supplemental Biologics License Application for Gazyva/Gazyvaro in primary membranous nephropathy. This review status, supported by phase III MAJESTY trial data showing superiority to tacrolimus in achieving complete remission, puts regulatory timing and potential label expansion for Roche Holding on investors’...

Shareholders might have noticed that Volvo Car AB (publ.) ( STO:VOLCAR B ) filed its interim result this time last...

It looks like Desarrollos Especiales de Sistemas de Anclaje, S.A. ( BME:DESA ) is about to go ex-dividend in the next 4...

Last week, you might have seen that CAG Group AB (publ) ( STO:CAG ) released its second-quarter result to the market...

The second-quarter results for Apotea AB (publ) ( STO:APOTEA ) were released last week, making it a good time to...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

It's been a sad week for Avensia AB (publ) ( STO:AVEN ), who've watched their investment drop 12% to kr6.22 in the week...

As you might know, Komplett ASA ( OB:KOMPL ) just kicked off its latest quarterly results with some very strong...

Nolato AB (publ) ( STO:NOLA B ) shareholders are probably feeling a little disappointed, since its shares fell 3.6% to...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Last week, you might have seen that VBG Group AB (publ) ( STO:VBG B ) released its second-quarter result to the market...

It's been a good week for Bilia AB (publ) ( STO:BILI A ) shareholders, because the company has just released its latest...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

It's been a sad week for Lindab International AB (publ) ( STO:LIAB ), who've watched their investment drop 11% to kr120...